Delivery Order SPE2DB24D1104-SPE2DB25FXZW8
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of fluorescein sodium 10% vial 5ml, a medical supply item. The contract has a ceiling value of $9,734.20, is a firm fixed price delivery order, and has an ultimate completion date of November 20, 2024. The contract is not designated with a set-aside requirement....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $21,513.45, is a delivery order contract for the supply of fluorescein sodium 10% vial 5ml medical products. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,573.33, is a Firm Fixed Price Delivery Order for the supply of 4565639968 - Fluorescein Sodium 10% Vial 5ML. The contract has an ultimate completion date of September 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.40 firm-fixed price delivery order is for the supply of Fluorescein Sodium 10% Vial, 5 mL, a pharmaceutical product used in various medical applications. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of 4,563,063,132 units of Fluorescein Sodium 10% Vial 5ML. The order is valued at $10,177.00 and has a completion date of December 12, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluorescein Sodium 10% vial (5 mL). The contract is a firm-fixed-price Delivery Order with a ceiling value of $7,542.10 and a period of performance through June 5, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluorescein Sodium 10% Vial 5ML. The contract has a firm fixed price of $1,942.33 and a completion date of June 12, 2025. The contract is not set-aside and was awarded on June 11, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies,...
This federal contract award is for the delivery of 5 mL vials of 10% Fluorescein Sodium, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,066.33, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 4, 2024. The contract is a Firm Fixed Price Delivery Order with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $4,234.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DX15D1053|SPE2DX25F6MXD) for the supply of 4568093522 - Fluorescein Sodium 10% Vial 5ML, with a firm fixed price and a performance period through May 1, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 5 ml vials of 10% Fluorescein Sodium. The contract is a firm fixed-price delivery order valued at $2,218.77, with a period of performance ending on March 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...